Clinical Trials Logo

Sarcopenia clinical trials

View clinical trials related to Sarcopenia.

Filter by:

NCT ID: NCT06049914 Recruiting - Sarcopenia Clinical Trials

Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care

Start date: August 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the impact of a combined exercise-nutrition intervention in primary clinics on sarcopenia indices, physical function, and quality of life in community-dwelling older adults with possible sarcopenia.

NCT ID: NCT06040905 Recruiting - Alzheimer Disease Clinical Trials

Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor

Start date: December 26, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to investigate the effect of coenzyme Q10 supplementation (150 mg/b.i.d, 300 mg/d, 12 weeks) on coenzyme Q10, glucose parameters, BDNF, myokines, and cognitive function in mild cognitive impairment (MCI) and Alzheimer's disease (AD) patients who combined with hyperglycemia but without sarcopenia, or with hyperglycemia and pre-sarcopenia.

NCT ID: NCT06040814 Recruiting - Clinical trials for Hepatic Encephalopathy

Microbiota, Sarcopenia, and Hepatic Encephalopathy Change in Cirrhotic Patients Before and After Rehabilitation

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Through this plan, it will provide many benefits to patients with liver cirrhosis complicated with sarcopenia and/or hepatic encephalopathy, their family members, and the government in Taiwan: 1. To explore the changes of fecal microbiota before and after treatment such as resistance training rehabilitation in patients with liver cirrhosis complicated with sarcopenia and/or hepatic encephalopathy as a reference for future fecal microbiota transplantation; 2. To measure the changes of sarcopenia level before and after rehabilitation; 3. To measure the changes of hepatic encephalopathy level before and after rehabilitation. These study results will certainly bring updated diagnostic tool, latest treatment options, avoid serious sequelae and reduce medical expenditure.

NCT ID: NCT06040125 Recruiting - PROSTATE CANCER Clinical Trials

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a 16-week supervised, clinic-based circuit training intervention utilizing resistance and functional exercises and self-directed aerobic exercise will improve frailty and sarcopenic status and disease progression outcomes among pre-frail/frail metastatic prostate cancer patients receiving androgen deprivation therapy (ADT). The names of the study intervention involved in this study is: • Supervised circuit training (aerobic and resistance exercise regimen)

NCT ID: NCT06038500 Completed - Sarcopenia Clinical Trials

Multicomponent Intervention in Women at Risk of Sarcopenia

Start date: June 3, 2019
Phase: N/A
Study type: Interventional

The goal of this quasi-experimental pilot study is to evaluate the effect of a multi-component intervention in women between 55 and 75 years old at risk of sarcopenia. The main question it aims to answer are: What is the effect of a multi-component intervention in women at risk of sarcopenia? Participants will twelve women between 55 and 75 years old with risk of sarcopenia, who agreed through written informed consent for participate 12 weeks with 24 sessions included dancing, resistance exercises, and nutritional education. The outcomes were muscle mass, grip strength, gait speed and body composition. The effects were measured before and after the intervention, under a self-controlled design.

NCT ID: NCT06031766 Recruiting - Malnutrition Clinical Trials

Comparison of CIPA With the GLIM Criteria and Prevalence of Sarcopenia in Inpatients

Start date: January 7, 2022
Phase:
Study type: Observational

Determine the diagnostic quality of the CIPA tool, in inpatients with stays longer than three days, in the observation of risk of malnutrition compared to the gold standard GLIM as a diagnosis of malnutrition.

NCT ID: NCT06017245 Completed - Osteoporosis Clinical Trials

The Bone-Myoregulation Reflex and Development of Sarcopenia in Osteoporosis

Start date: August 29, 2023
Phase: N/A
Study type: Interventional

Bone and skeletal muscle are in a single unit that interacts with each other structurally and functionally. The aim of this study is to determine the contribution of bone myoregulation reflex as a neuronal crosstalk mechanism on the development of sarcopenia in postmenopausal and senile osteoporosis

NCT ID: NCT06015971 Recruiting - Sarcopenia Clinical Trials

Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

Sarcopenia is a frequent complication in patients with cancer and chronic diseases, it is characterized by decreased muscle strength and fatigue due to reduced skeletal muscle mass, which is accompanied by atrophy and decreased quality of muscle tissue. In all cases, it negatively impacts treatment tolerance, clinical outcomes and survival, in consequence, quality of life of these patients decreases while morbidity, mortality and costs increase. In this context, appropriate nutritional screening and early nutrition support are extremely recommended, to this aim, in some cases, oral nutritional supplements (ONS) are necessary; ONS could have a standard formula or be enriched with specific nutrients (arginine, glutamine, branched chain amino acids, n-3 fatty acids, and nucleotides), which can modulate the activity of the immune system and provide an additional benefit beyond the nutritional support, this intervention type is called immunonutrition. Despite these possible benefits, their utility has been proven in few clinical scenarios, for example in with patients with upper gastrointestinal cancer undergoing surgical resection; based on this, current guidelines recommend that patients should receive oral/enteral nutritional support with an specific formula enriched in immunonutrients (with arginine, n-3 fatty acids or nucleotides) , but there is a lack of evidence for supporting its use in other clinical conditions including patients with cancer that receive systemic treatment

NCT ID: NCT06012422 Not yet recruiting - Sarcopenia Clinical Trials

Sarcopenia Screening in Elderly Individuals

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

In this study, it is aimed to evaluate parameters such as sarcopenia screening, muscle mass measurement, loss of strength that may develop due to sarcopenia, loss of balance and related fall, decrease in functionality, fragility and decreased physical activity in individuals aged 65 years and older in Kırıkkale city center.

NCT ID: NCT06005064 Recruiting - Sarcopenia Clinical Trials

Middle Age muScle Krill Study

MASK
Start date: November 1, 2023
Phase: N/A
Study type: Interventional

This study will determine the effect of 6 months of supplementation with krill oil on muscle strength and mass in middle-aged adults. The study hypothesis is that krill oil supplementation will increase muscle strength and mass in middle-aged adults.